Type: Society Project page: Access page Country: Switzerland Synopsis: The Swiss Biotech Association is a non-profit, member-driven organization representing the interests of the Swiss biotech industry. Swiss biotech companies are leading the way in developing and commercializing innovative medicines, diagnostics, healthcare treatments, services and enabling technologies.
Type: Infrastructure Project page: Access page Country: Switzerland Synopsis: The Swiss Personalized Health Network is a national initiative under the leadership of the Swiss Academy of Medical Sciences (SAMS). In collaboration with the SIB Swiss Institute of Bioinformatics it contributes to the development, implementation and validation of coordinated data infrastructures in order to make health-relevant...
Type: Research Project page: Access page Country: Switzerland Synopsis: The Center is dedicated to advancing precision medicine approaches by fostering the research and development of medical treatments and therapy methods. It provides an interdisciplinary platform for researchers and clinicians from different departments and faculties. The Center will also engage with graduate schools to offer training...
Dates: 01/01/2021 31/12/2025 Topic: Tool Procedures Project type: Preclinic Project target: Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSITAETSKLINIKUM WUERZBURG – KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT Keywords: Countries: Germany; UK; Italy; France; Austria; Spain; Belgium; Luxembourg; Switzerland Project page: Access page...
Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...
Dates: 01/09/2021 31/08/2025 Topic: Tool Project type: Preclinic Project target: Other Financing: H2020-EU.1.2. – EXCELLENT SCIENCE – Future and Emerging Technologies (FET) H2020-EU.1.2.1. – FET Open Participating agents: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS Keywords: protein; biosensor; cell biology; biophysic; LEDIs; electrodynamic interactions Countries: France; Switzerland; Germany; Nehterlands Project page: Access page
Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...
Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...
Dates: 01/012021 31/12/2025 Topic: Biomarkers identification Project type: Preclinic Immunotherapy Project target: Autoimmune disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: UNIVERSITAT ZURICH Keywords: Neurobiology; MS; inflammatory disease; stem cell; biomarker; mapping; twin pair Countries: Switzerland Project page: Access page
Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...